Your browser does not support JavaScript! DOCUSATE SODIUM LIQUID [CARDINAL HEALTH]
DailyMed Logo Header image

Daily Med

Current Medication Information

Options

RxNorm Names

DOCUSATE SODIUM liquid
[Cardinal Health]


Category DEA Schedule Marketing Status
HUMAN OTC DRUG LABEL unapproved drug other
NOTE:THIS DRUG HAS NOT BEEN FOUND BY FDA TO BE SAFE AND EFFECTIVE, AND THIS LABELING HAS NOT BEEN APPROVED BY FDA. For further information about unapproved drugs, click here.
Drug Label Sections

Active ingredient

Each 5 ml (teaspoonful) contains docusate sodium 50 mg.

Purpose

Stool Softener Laxative

Keep Out of Reach of Children

Keep this and all drugs out of the reach of children. In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.

Uses

For relief of occasional constipation due to hard stools. The effect on stools is usually apparent 1 to 3 days after the first dose.

Warnings

Do not use laxative products when abdominal pain, nausea, or vomiting are present, or use for a period longer than 1 week, unless directed by a physician. If you have noticed a sudden change in bowel habits that persists over a period of 2 weeks, consult a physician before using a laxative. Rectal bleeding or failure to have a bowel movement after the use of a laxative may indicate a serious condition. Discontinue use and consult you physician. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health professional before using this product. May cause rash in some cases.

DRUG INTERACTION PRECAUTION: Do not take this product if you are presently taking mineral oil or a prescription drug, unless directed by a physician.

Directions

As directed by a physician or once daily as follows: Adults and children 12 years of age and over: oral dosage is 5 to 20 mL (1 to 4 teaspoonfuls). Children 6 to under 12 years of age: oral dosage is 5 to 10 mL (1 to 2 teaspoonfuls). Children 3 to under 6 years of age: oral dosage is 2.5 to 5 mL (1/2 to 1 teaspoonful). Children under 3 years of age: consult a physician. The higher doses are recommended for initial therapy. Dosage should be adjusted to individual response. If desired, the product may be administered in a 6 to 8 oz glass of milk or fruit juice or in infant formula to mask the bitter taste.

Inactive ingredients

Sugar Free

Citric acid, D&C Red No. 33, flavoring, glycerin, propylene glycol, purified water, sodium citrate, sodium saccharin, and sorbitol.

Sodium Content: 14 mg/5 ml

Indications

For the relief of occasional constipation due to hard stools. The effect on stools is usually apparent 1 to 3 days after the first dose.

Drug Interaction Precaution

Do not take this product if you are presently taking mineral oil or a prescription drug, unless directed by a physician.

How Supplied

Purple colored, cherry flavored liquid supplied in the following oral dosage forms: NDC 0121-0544-10

(unit dose cups of 10 mL, 10 x 10's), NDC 0121-0544-25

(unit dose cups of 25 mL, 10 x 10's), and NDC 0121-0544-16

(16 fl oz bottle).

Storage

Keep tightly closed. Store at controlled room temperature, 20°-25°C (68°-77°F). Protect from freezing. Protect from light.

Pharmaceutical Associates, Inc.

Greenville, SC 29605

R01/01

Principal Display Panel

Docusate Sodium Liquid

100 mg/10 ml

Stool Softener Laxative

5 Unit Dose Cups

bag label
DOCUSATE SODIUM 
docusate sodium liquid
Product Information
Product TypeHUMAN OTC DRUG LABELItem Code (Source)NDC:55154-9401(NDC:0121-0544)
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM100 mg  in 10 mL
Inactive Ingredients
Ingredient NameStrength
CITRIC ACID MONOHYDRATE 
D&C RED NO. 33 
GLYCERIN 
PROPYLENE GLYCOL 
WATER 
SODIUM CITRATE 
SACCHARIN SODIUM 
SORBITOL 
Product Characteristics
ColorPURPLEScore    
ShapeSize
FlavorCHERRYImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:55154-9401-55 in 1 BAG
110 mL in 1 CUP, UNIT-DOSE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other06/02/2011
Labeler - Cardinal Health (188557102)
Establishment
NameAddressID/FEIBusiness Operations
Cardinal Health188557102REPACK

Revised: 6/2011
 
Cardinal Health

Visit The National Library of Medicine Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services